Literature DB >> 21288159

Heme oxygenase-1 induction enhances cell survival and restores contractility to unvascularized three-dimensional adult cardiomyocyte grafts implanted in vivo.

Shunsuke Kawamoto1, Jerald P Flynn, Qun Shi, Sana W Sakr, Jun Luo, Margaret D Allen.   

Abstract

Autologous adult cardiomyocytes are not utilized for heart repair strategies because of their rapid apoptosis after implantation. We examined whether induction of heme oxygenase-1 (HO-1), a mediator of preconditioning, could enhance early postimplant myocyte survival. Three-dimensional 5×5 mm patches of full-thickness adult murine atrial wall, including cardiomyocytes, capillary networks, and extracellular matrix, were cultured with or without HO-1 inducer cobalt protoporphyrin (CoPP), or the HO-1 inhibitor, tin protoporphyrin (SnPP), or both. Patches were then implanted subcutaneously. Freshly procured atrial wall patches implanted without preculturing served as additional controls. By 14 days postimplant, graft cardiomyocyte content was significantly greater in CoPP-treated patches than in either control group (p<0.02). Adult cardiomyocytes did not contract in culture or immediately after implantation. However, by 14 days postimplant, spontaneous contraction had recovered in 47% of CoPP-treated patches, but in only 6% of precultured patches without CoPP, 0% of SnPP-treated patches, and 0% of uncultured patches (p<0.03). CoPP-treated adult cardiomyocyte patches were also observed to remodel spontaneously into endothelial-lined chambers that pumped nonclotting blood. These findings demonstrate that adult cardiomyocytes have more plasticity and capacity for functional recovery than previously recognized and could have application as an autologous cardiomyocyte source for tissue engineering.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21288159      PMCID: PMC3098958          DOI: 10.1089/ten.TEA.2010.0447

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  75 in total

1.  Autologous heart cell transplantation improves cardiac function after myocardial injury.

Authors:  T Sakai; R K Li; R D Weisel; D A Mickle; E J Kim; S Tomita; Z Q Jia; T M Yau
Journal:  Ann Thorac Surg       Date:  1999-12       Impact factor: 4.330

2.  Biliverdin reductase: a major physiologic cytoprotectant.

Authors:  David E Baranano; Mahil Rao; Christopher D Ferris; Solomon H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-27       Impact factor: 11.205

3.  Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart.

Authors:  Guangwu Wang; Tariq Hamid; Rachel J Keith; Guihua Zhou; Charles R Partridge; Xilin Xiang; Justin R Kingery; Robert K Lewis; Qianhong Li; D Gregg Rokosh; Rachael Ford; Francis G Spinale; Daniel W Riggs; Sanjay Srivastava; Aruni Bhatnagar; Roberto Bolli; Sumanth D Prabhu
Journal:  Circulation       Date:  2010-04-19       Impact factor: 29.690

4.  A vigilant, hypoxia-regulated heme oxygenase-1 gene vector in the heart limits cardiac injury after ischemia-reperfusion in vivo.

Authors:  Yao Liang Tang; Keping Qian; Y Clare Zhang; Leping Shen; M Ian Phillips
Journal:  J Cardiovasc Pharmacol Ther       Date:  2005-12       Impact factor: 2.457

Review 5.  Heme oxygenase and carbon monoxide initiate homeostatic signaling.

Authors:  Martin Bilban; Arvand Haschemi; Barbara Wegiel; Beek Y Chin; Oswald Wagner; Leo E Otterbein
Journal:  J Mol Med (Berl)       Date:  2007-11-22       Impact factor: 4.599

6.  Improved long-term graft survival after HO-1 induction in brain-dead donors.

Authors:  K Kotsch; M Francuski; A Pascher; R Klemz; M Seifert; J Mittler; G Schumacher; R Buelow; H-D Volk; S G Tullius; P Neuhaus; J Pratschke
Journal:  Am J Transplant       Date:  2006-03       Impact factor: 8.086

Review 7.  Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis.

Authors:  Jozef Dulak; Jessy Deshane; Alicja Jozkowicz; Anupam Agarwal
Journal:  Circulation       Date:  2008-01-15       Impact factor: 29.690

8.  Carbon monoxide protects against cardiac ischemia--reperfusion injury in vivo via MAPK and Akt--eNOS pathways.

Authors:  Hajime Fujimoto; Minoru Ohno; Seiji Ayabe; Hisae Kobayashi; Nobukazu Ishizaka; Hiroko Kimura; Ken-ichi Yoshida; Ryozo Nagai
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-08-12       Impact factor: 8.311

9.  Thrombomodulin and tissue factor pathway inhibitor in endocardium of rapidly paced rat atria.

Authors:  Takeshi Yamashita; Akiko Sekiguchi; Yu-ki Iwasaki; Kouichi Sagara; Seiji Hatano; Hiroyuki Iinuma; Tadanori Aizawa; Long-Tai Fu
Journal:  Circulation       Date:  2003-11-10       Impact factor: 29.690

10.  Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts.

Authors:  Masato Nakagawa; Michiyo Koyanagi; Koji Tanabe; Kazutoshi Takahashi; Tomoko Ichisaka; Takashi Aoi; Keisuke Okita; Yuji Mochiduki; Nanako Takizawa; Shinya Yamanaka
Journal:  Nat Biotechnol       Date:  2007-11-30       Impact factor: 54.908

View more
  8 in total

1.  The heme oxygenase 1 inducer (CoPP) protects human cardiac stem cells against apoptosis through activation of the extracellular signal-regulated kinase (ERK)/NRF2 signaling pathway and cytokine release.

Authors:  Chuanxi Cai; Lei Teng; Duc Vu; Jia-Qiang He; Yiru Guo; Qianghong Li; Xian-Liang Tang; Gregg Rokosh; Aruni Bhatnagar; Roberto Bolli
Journal:  J Biol Chem       Date:  2012-08-09       Impact factor: 5.157

2.  Can Cytoprotective Cobalt Protoporphyrin Protect Skeletal Muscle and Muscle-derived Stem Cells From Ischemic Injury?

Authors:  Heather-Marie P Wilson; Robert E Welikson; Jun Luo; Thomas J Kean; Baohong Cao; James E Dennis; Margaret D Allen
Journal:  Clin Orthop Relat Res       Date:  2015-09       Impact factor: 4.176

3.  Inhibition of CYP2E1 attenuates chronic alcohol intake-induced myocardial contractile dysfunction and apoptosis.

Authors:  Rong-Huai Zhang; Jian-Yuan Gao; Hai-Tao Guo; Glenda I Scott; Anna R Eason; Xiao-Ming Wang; Jun Ren
Journal:  Biochim Biophys Acta       Date:  2012-09-02

4.  Lung endothelial HO-1 targeting in vivo using lentiviral miRNA regulates apoptosis and autophagy during oxidant injury.

Authors:  Yi Zhang; Ge Jiang; Maor Sauler; Patty J Lee
Journal:  FASEB J       Date:  2013-06-14       Impact factor: 5.191

5.  Cobalt protoporphyrin pretreatment protects human embryonic stem cell-derived cardiomyocytes from hypoxia/reoxygenation injury in vitro and increases graft size and vascularization in vivo.

Authors:  Jun Luo; Matthew S Weaver; Baohong Cao; James E Dennis; Benjamin Van Biber; Michael A Laflamme; Margaret D Allen
Journal:  Stem Cells Transl Med       Date:  2014-04-15       Impact factor: 6.940

6.  Targeting survival pathways to create infarct-spanning bridges of human embryonic stem cell-derived cardiomyocytes.

Authors:  Jun Luo; Matthew S Weaver; James E Dennis; Elizabeth Whalen; Michael A Laflamme; Margaret D Allen
Journal:  J Thorac Cardiovasc Surg       Date:  2014-07-24       Impact factor: 5.209

7.  Heme oxygenase-1 induction improves cardiac function following myocardial ischemia by reducing oxidative stress.

Authors:  Yossi Issan; Ran Kornowski; Dan Aravot; Asher Shainberg; Michal Laniado-Schwartzman; Komal Sodhi; Nader G Abraham; Edith Hochhauser
Journal:  PLoS One       Date:  2014-03-21       Impact factor: 3.240

8.  Preconditioning Human Cardiac Stem Cells with an HO-1 Inducer Exerts Beneficial Effects After Cell Transplantation in the Infarcted Murine Heart.

Authors:  Chuanxi Cai; Yiru Guo; Lei Teng; Yibing Nong; Min Tan; Michael J Book; Xiaoping Zhu; Xiao-Liang Wang; Junjie Du; Wen-Jian Wu; Wei Xie; Kyung U Hong; Qianhong Li; Roberto Bolli
Journal:  Stem Cells       Date:  2015-09-23       Impact factor: 6.277

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.